Clinical trial
Glycine to Treat Psychotic Disorders in Children
NCT00005658 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00005658 |
|---|---|
| Title | Glycine to Treat Psychotic Disorders in Children |
| Official title | Childhood Onset Psychotic Disorders: An Open Trial With the Amino Acid Glycine |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Psychotic Disorder, Schizoaffecitve Disorder, Schizophrenia |
| Intervention type | Drug |
| Interventions | Glycine |
| Enrollment | 10 |
| Start date | May 1, 2000 |
| Completion | Jan 1, 2002 |
| First posted | May 10, 2000 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: